文献速递血栓与止血

低白蛋白血症患者静脉血栓栓塞症与动脉事件风险:超过200万患者的综合荟萃分析

Risk of venous thromboembolism and arterial events in patients with hypoalbuminemia: a comprehensive meta-analysis of more than 2 million patients.
PubMed 文献 · J Thromb Haemost · 2024-07-04

该荟萃分析纳入43项观察性研究与随机试验、共2 531 091例患者,评估低白蛋白血症(血清白蛋白<3.5 g/dL)与静脉血栓栓塞症(VTE)及动脉事件风险的关系。低白蛋白血症患者VTE风险升高(RR 1.88,95%CI 1.66-2.13),内科与外科患者、合并与未合并癌症者结果相似;心肌梗死与卒中风险亦升高。

要点

  • 低白蛋白血症患者VTE风险升高(RR 1.88,95%CI 1.66-2.13)。
  • 内科与外科患者、合并与未合并癌症者VTE风险比相似。
  • 低白蛋白血症患者心肌梗死与卒中风险亦升高。

核心结论

  • 低白蛋白血症是内科和外科患者VTE的危险因素,无论是否合并癌症。
  • 血清白蛋白分析可能是识别VTE风险患者的简单且廉价的工具。

研究设计与样本

  • 检索MEDLINE和EMBASE至2024年1月,纳入报告相关数据的观察性研究和随机试验。
  • 共纳入43项研究、2 531 091例患者(内科39 738例,外科2 491 353例)。
  • 79.1%的研究采用3.5 g/dL作为低白蛋白血症定义切点。
  • 60.5%的研究随访时间为30天。
  • 采用Newcastle-Ottawa量表和Cochrane工具评估偏倚风险,以随机效应模型计算风险比(RR)及95%置信区间(CI)。

主要发现

  • 低白蛋白血症患者VTE风险升高(RR 1.88,95%CI 1.66-2.13)。
  • 内科患者VTE风险RR 1.87(95%CI 1.53-2.27),外科患者RR 1.87(95%CI 1.61-2.16)。
  • 合并癌症患者VTE风险RR 1.86(95%CI 1.66-2.10),未合并癌症患者RR 1.89(95%CI 1.47-2.44)。
  • 低白蛋白血症患者心肌梗死风险升高(RR 1.88,95%CI 1.54-2.31)。
  • 低白蛋白血症患者卒中风险升高(RR 1.77,95%CI 1.26-2.48)。

关键数值与推荐

  • 低白蛋白血症定义为血清白蛋白<3.5 g/dL。
  • 主要结局为VTE风险,次要结局为心肌梗死和卒中风险。

临床怎么用

  • 原文结论认为血清白蛋白分析可能是识别VTE风险患者的简单且廉价的工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Albumin has antiplatelet and anticoagulant functions. Hypoalbuminemia, as defined by serum values of <3.5 g/dL, is associated with arterial thrombosis; its impact on venous thromboembolism (VTE) is unclear. OBJECTIVES: The objective of this meta-analysis is to assess the VTE risk in patients with hypoalbuminemia. METHODS: MEDLINE and EMBASE were searched up to January 2024 for observational studies and randomized trials reporting data of interest. Primary outcome was the risk of VTE, while secondary outcomes were myocardial infarction and stroke risk in patients with hypoalbuminemia versus those without hypoalbuminemia. The risk of bias was evaluated using Newcastle-Ottawa scale and Cochrane tool. Risk ratios (RRs) with 95% confidence intervals (CIs) were calculated in a random-effects model. RESULTS: Forty-three studies for a total of 2 531 091 patients (39 738 medical and 2 491 353 surgical) were included in primary analysis; 79.1% of the studies used 3.5 g/dL cut-off value for hypoalbuminemia definition. Follow-up duration was 30 days in 60.5% of studies. Patients with hypoalbuminemia had a higher risk of VTE (RR, 1.88; 95% CI, 1.66-2.13). RRs were similar in both medical (RR, 1.87; 95% CI, 1.53-2.27) and surgical patients (RR, 1.87; 95% CI, 1.61-2.16) and in patients with (RR, 1.86; 95% CI, 1.66-2.10) and without cancer (RR, 1.89; 95% CI, 1.47-2.44). Risk of myocardial infarction (RR, 1.88; 95% CI, 1.54-2.31) and stroke (RR, 1.77; 95% CI, 1.26-2.48) was higher in patients with hypoalbuminemia. CONCLUSION: Hypoalbuminemia is a risk factor for VTE in both medical and surgical patients irrespective of cancer coexistence. Serum albumin analysis may represent a simple and cheap tool to identify patients at VTE risk.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Valeriani E, Pannunzio A, Palumbo IM, et al. Risk of venous thromboembolism and arterial events in patients with hypoalbuminemia: a comprehensive meta-analysis of more than 2 million patients. J Thromb Haemost. 2024. PMID: 38971499. doi:10.1016/j.jtha.2024.06.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。